NAFLDsym® is Quantitative Systems Pharmacology (QSP) Software Capable of Exploring and Predicting Efficacy for Novel NASH Treatments.
DILIsym® X Product Brochure
DILIsym is Quantitative Systems Toxicology (QST) software capable of predicting and explaining Drug-Induced Liver Injury (DILI).
Plug n’ Play PBBM
The GastroPlus Plug n' Play PBBM Packages
GastroPlus® Additional Dosage Routes Brochure
Trust Our Gut... and Model Everywhere!
GastroPlus® v9.8.3 Product Brochure
GastroPlus® is a mechanistically based simulation software package that simulates intravenous, oral, oral cavity, ocular, inhalation, dermal/ subcutaneous, and intramuscular absorption, pharmacokinetics, and...
MembranePlus v3 Product Brochure
Your modeling tool for IVIVE of absorption and systemic clearance/distribution processes…
DDDPlus Product Brochure
Simulation software for the in vitro dissolution experiment of pharmaceutical dosage forms
MonolixSuite™ v2021 Product Brochure
A fast easy-to-use and powerful suite of applications for pharmacometrics analysis, modeling and simulation.
ADMET Predictor® Product Brochure
ADMET Predictor® is a software package that quickly and accurately predicts over 140 absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties.
IPFsym™ Product Brochure
State of the art QSP software for idiopathic pulmonary fibrosis (IPF)
DDDPlus™ Product Brochure
Software for the in vitro dissolution experiment of pharmaceutical dosage forms
MonolixSuite™ Product Brochure
A fast easy-to-use and powerful suite of applications for pharmacometrics analysis, modeling and simulation
NAFLDsym® Product Brochure
NAFLDsym® is Quantitative Systems Pharmacology (QSP) Software Capable of Exploring and Predicting Efficacy for Novel NASH Treatments.
DILIsym® Product Brochure
DILIsym is Quantitative Systems Toxicology (QST) software capable of predicting and explaining Drug-Induced Liver Injury (DILI).
An On-Site 2-Day Workshop in Engineering The Pharmacometric Enterprise A Workshop For Improving the Efficiency and Effectiveness of Model-Based Drug Development
This workshop has been developed in response to the growing recognition that increasing the efficiency and effectiveness of the pharmacometric analysis process is a critical prerequisite for the successful transition to model -based drug development.
MembranePlus Product Brochure
Your modeling tool for IVIVE of absorption and systemic clearance/distribution processes…